| Catherine Berglund, LVN | |
|
120 Pebble Beach Ct, Winchester, OR 97495 | |
| (301) 260-0042 | |
| Not Available |
| Full Name | Catherine Berglund |
|---|---|
| Gender | Female |
| Speciality | Licensed Vocational Nurse |
| Location | 120 Pebble Beach Ct, Winchester, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508218082 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164X00000X | Licensed Vocational Nurse | VN 134942 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Catherine Berglund, LVN 120 Pebble Beach Ct., Winchester, OR 97495 Ph: (301) 260-0042 | Catherine Berglund, LVN 120 Pebble Beach Ct, Winchester, OR 97495 Ph: (301) 260-0042 |
News Archive
Noting USAID on Wednesday released USAID Forward, "a progress report on its three-year-old reform effort ... which in the words of Administrator Rajiv Shah has the ultimate goal of putting 'ourselves out of business,'" Bill Lane, the director of International Governmental Affairs for Caterpillar, and Carolyn Miles, president and CEO of Save the Children - co-presidents of the U.S. Global Leadership Coalition - write in The Hill's "Congress Blog," "We applaud the goals of USAID Forward to modernize and strengthen U.S. development programs, and while every indicator in the report is not perfect, the reforms are moving in the right direction."
Participants in a two-year, lifestyle intervention/weight-loss program provided through health coaches at their primary care center were able to lower their blood sugar and improve their cholesterol levels, according to new research published today in the American Heart Association's flagship journal Circulation Journal.
FibroGen, Inc., today announced proof-of-principle for oral anemia therapy FG-4592, a hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitor, in end-stage renal disease patients receiving hemodialysis.
Diffusion weighted (DW) magnetic resonance imaging (MRI) is a widely used technique to detect and characterize cancers as well as to monitor response to therapy. DW-MRI offers numerous advantages for patients with cancer and their treating physicians. It is a non-invasive imaging tool which does not require the administration of contrast agents nor ionizing radiation.
A simple information and communication intervention between a patient and physician can increase hospice referral rates among nursing home residents, increase their families' ratings of end-of-life care, and may decrease use of acute care resources, according to an article in the July 13 issue of JAMA: The Journal of the American Medical Association.
› Verified 5 days ago